Telehealth extended but details remain limited The RACGP has cautiously welcomed the six month extension but is still waiting to confirm the policy’s final details.
Are blood clots a concern with mRNA vaccines? An investigation into Australia’s first case of blood clotting after the Pfizer vaccine has yet to confirm a link.
GPs set to receive more AstraZeneca doses in fast-tracked rollout The shift means people over 50 will have access to COVID vaccines from GP respiratory clinics from 3 May, and general practices from 17 May.
Funding for in-home COVID vaccine assessments ‘inadequate’ GPs have questioned the lack of a dedicated MBS item number for housebound patients.
Blood clot case under investigation following Pfizer vaccine The news comes as Australia moves to establish local mRNA manufacturing capacity and experts call for current Pfizer supplies to be redirected to younger cohorts.
Major reset to vaccination program: What will it mean for GPs? GPs have welcomed the National Cabinet’s proposal to revise the vaccine roadmap but say supply issues must be addressed before any major changes are made.
What would it take for Australia to manufacture mRNA vaccines? Experts say investing in RNA technology now will help to protect Australia, and its neighbours, beyond the current pandemic.
‘Seeds of fear and mayhem’: Concerns media hindering vaccine rollout Journalists have a responsibility to not undermine the science and contribute to issues of vaccine hesitancy, according to the RACGP President.
Deaths in custody: ‘Every Aboriginal family has a story’ It’s been 30 years since the royal commission first tabled its recommendations and GPs are calling for more action.
Blood clots, supply issues, new technologies: Does Australia need another COVID vaccine option? After delays with Novavax, advising against AstraZeneca for under-50s, and ruling out Johnson & Johnson, what are the Government’s remaining options?